PLIVA, Inc., et al. v. Mensing; Actavis Elizabeth, LLC v. Mensing; Actavis, Inc., v. Demahy

Docket Number09-993,09-1039,09-1501
Decision Date23 June 2011
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex

Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant

  • Access comprehensive legal content with no limitations across vLex's unparalleled global legal database

  • Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength

  • Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities

  • Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting

vLex
837 cases
  • Exela Pharma Scis., LLC v. Sandoz, Inc.
    • United States
    • U.S. District Court — Western District of North Carolina
    • September 15, 2020
    ...federal agency, that party cannot independently satisfy those state duties for pre-emption purposes." PLIVA, Inc. v. Mensing, 564 U.S. 604, 623-24, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011). That is because "[t]he only action the [Defendant] could independently take—asking for the FDA's help—i......
  • Just Puppies, Inc. v. Frosh
    • United States
    • U.S. District Court — District of Maryland
    • May 6, 2020
    ...Pharm. Co., Inc. v. Bartlett , 570 U.S. 472, 480, 133 S.Ct. 2466, 186 L.Ed.2d 607 (2013) ); see also PLIVA, Inc. v. Mensing , 564 U.S. 604, 617, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011) ; Freightliner Corp. v. Myrick , 514 U.S. 280, 287, 115 S.Ct. 1483, 131 L.Ed.2d 385 (1995). This occurs whe......
  • Portland Pipe Line Corp. v. City of S. Portland
    • United States
    • U.S. District Court — District of Maine
    • December 29, 2017
    ...Mktg. & Sales Practices Litig. , 779 F.3d 34, 41 (1st Cir. 2015) (internal quotations omitted) (citing PLIVA, Inc. v. Mensing , 564 U.S. 604, 621, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011) ; Wyeth v. Levine , 555 U.S. 555, 573, 129 S.Ct. 1187, 173 L.Ed.2d 51 (2009) ). PPLC can and currently do......
  • Aaron v. Medtronic, Inc.
    • United States
    • U.S. District Court — Southern District of Ohio
    • September 22, 2016
    ...... to comply with the MDA's reporting requirements does not constitute a ‘parallel claim.’ "); cf. PLIVA, Inc. v. Mensing , 564 U.S. 604, 131 S.Ct. 2567, 2578, 180 L.Ed.2d 580 (2011) ("State law demanded a safer label; it did not instruct the Manufacturers to communicate with the FDA").Pla......
  • Get Started for Free
63 firm's commentaries
  • Products Liability Update - May 2012 - Part 1
    • United States
    • Mondaq United States
    • May 17, 2012
    ...unsettled questions regarding preemption in the context of nonprescription, over-the-counter (OTC) drugs. In PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011), the Supreme Court held that federal law preempted state law failure to warn claims asserted against generic drug manufacturers. The Co......
  • Alabama No Longer An Outlier State: Legislature Says 'No' To Innovator Liability
    • United States
    • Mondaq United States
    • December 23, 2015
    ...Miss. 2013). Minnesota Law Mensing v. Wyeth, Inc., 588 F.3d 603 (8th Cir. 2009), rev'd on other grounds sub nom. PLIVA, Inc. v. Mensing, 131 S. Ct. 2567 (2011), re-instated in relevant part, 658 F.3d 867 (8th Cir. 2011). Flynn v. Am. Home Prods. Corp., 627 N.W.2d 342 (Minn. Ct. App. 2001). ......
  • Bartlett Pairs – “Failure To Recall” As a “Stop-Selling” Variant
    • United States
    • LexBlog United States
    • June 10, 2024
    ...for the plaintiffs in Bartlett I, while the strict liability verdict they had received was being appealed, PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011), happened. Since they were also suing over a generic drug, plaintiffs had to abandon their strict liability claims as preempted by Mensing, ......
  • Does 'Mutual Pharmaceutical Co., Inc. v. Bartlett' Herald The Demise Of The 'Failure-To-Withdraw' Theory?
    • United States
    • Mondaq United States
    • July 31, 2013
    ...and (iii). Federal law prohibits generic pharmaceutical manufacturers from independently changing their drugs' labels. PLIVA v. Mensing, 131 S. Ct. 2567, 180 L.Ed. 2d 580 (2011) (failure-to-warn claims against generic manufacturers are pre-empted by the FDCA's prohibition on changes to gene......
  • Get Started for Free
22 books & journal articles
  • Preemption and Commerce Clause Issues
    • United States
    • ABA Antitrust Library Business Torts and Unfair Competition Handbook Business tort litigation
    • January 1, 2014
    ...Corp., 331 U.S. 218, 230 (1947). 11. English, 496 U.S. at 79; Jones, 430 U.S. at 525; Rice, 331 U.S. at 230. 12. PLIVA, Inc. v. Mensing, 131 S. Ct. 2567, 2577 (2011); Hillsborough Cnty., Fla. v. Automated Med. Labs., 471 U.S. 707, 713 (1985). 13. Florida Lime & Avocado Growers v. Paul, 373 ......
  • CHAPTER § 9.02 Common Defenses
    • United States
    • Full Court Press Regulation of Pharmaceutical Manufacturers Title CHAPTER 9 Product Liability
    • Invalid date
    ...Inc., 588 F.3d 603, 613-14 (8th Cir. 2009) (applying Minnesota law), rev'd in part on other grounds sub nom., PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011), reaffirmed in pertinent part and vacated on other grounds, 658 F.3d 867 (8th Cir. 2011); Bell v. Pfizer, Inc., 716 F.3d 1087, 1092-93 (8......
  • Interpreting regulations.
    • United States
    • Michigan Law Review Vol. 111 No. 3, December 2012
    • December 1, 2012
    ...qualify for Seminole Rock deference, rejecting the argument that under Mead and Christensen they should not. See Pliva, Inc. v. Mensing, 131 S. Ct. 2567, 2575 n.3 (201 I) (relying on brief of United States); Chase Bank USA, N.A.v. McCoy, 131 S. Ct. 871. 883-84 (201 I) (rejecting argument th......
  • Summary Judgment
    • United States
    • ABA General Library ANDA litigation: strategies and tactics for pharmaceutical patent litigators. Second edition
    • June 23, 2016
    ...Inc., 496 U.S. 661, 676 (1990); Glaxo, Inc. v. Novopharm, Ltd., 110 F.3d 1562, 1568 (Fed. Cir. 1997); accord Pliva, Inc. v. Mensing, 131 S. Ct. 2567, 2582 (2011). 7. An ANDA does not require costly and time-consuming investigations showing the new generic drug is “safe in use” and “effectiv......
  • Get Started for Free

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT